BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15032778)

  • 21. Meta-analysis of pairs of survival curves under heterogeneity: a Poisson correlated gamma-frailty approach.
    Fiocco M; Putter H; van Houwelingen JC
    Stat Med; 2009 Dec; 28(30):3782-97. PubMed ID: 19899066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Truncated recurrent event survival models for methadone data.
    Salter A; Solomon PJ
    Biometrics; 1997 Dec; 53(4):1293-303. PubMed ID: 9423251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Partly conditional survival models for longitudinal data.
    Zheng Y; Heagerty PJ
    Biometrics; 2005 Jun; 61(2):379-91. PubMed ID: 16011684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Joint analysis of longitudinal data with informative right censoring.
    Liu M; Ying Z
    Biometrics; 2007 Jun; 63(2):363-71. PubMed ID: 17425632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analyzing multi-environment variety trials using randomization-derived mixed models.
    Caliński T; Czajka S; Kaczmarek Z; Krajewski P; Pilarczyk W
    Biometrics; 2005 Jun; 61(2):448-55. PubMed ID: 16011691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamic analysis of multivariate failure time data.
    Aalen OO; Fosen J; Weedon-Fekjaer H; Borgan O; Husebye E
    Biometrics; 2004 Sep; 60(3):764-73. PubMed ID: 15339300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Semiparametric analysis of survival data with left truncation and dependent right censoring.
    Jiang H; Fine JP; Chappell R
    Biometrics; 2005 Jun; 61(2):567-75. PubMed ID: 16011706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adaptive risk group refinement.
    LeBlanc M; Moon J; Crowley J
    Biometrics; 2005 Jun; 61(2):370-8. PubMed ID: 16011683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analyzing multivariate survival data using composite likelihood and flexible parametric modeling of the hazard functions.
    Nielsen J; Parner ET
    Stat Med; 2010 Sep; 29(20):2126-36. PubMed ID: 20809537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimation method of the semiparametric mixture cure gamma frailty model.
    Peng Y; Zhang J
    Stat Med; 2008 Nov; 27(25):5177-94. PubMed ID: 18613271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modeling late entry bias in survival analysis.
    Matsuura M; Eguchi S
    Biometrics; 2005 Jun; 61(2):559-66. PubMed ID: 16011705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dispersion frailty models and HGLMs.
    Noh M; Ha ID; Lee Y
    Stat Med; 2006 Apr; 25(8):1341-54. PubMed ID: 16217839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A joint frailty model for survival and gap times between recurrent events.
    Huang X; Liu L
    Biometrics; 2007 Jun; 63(2):389-97. PubMed ID: 17688491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Semiparametric regression in capture-recapture modeling.
    Gimenez O; Crainiceanu C; Barbraud C; Jenouvrier S; Morgan BJ
    Biometrics; 2006 Sep; 62(3):691-8. PubMed ID: 16984309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pseudo-likelihood estimation for a marginal multivariate survival model.
    Tibaldi F; Molenberghs G; Burzykowski T; Geys H
    Stat Med; 2004 Mar; 23(6):947-63. PubMed ID: 15027082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A class of Bayesian shared gamma frailty models with multivariate failure time data.
    Yin G; Ibrahim JG
    Biometrics; 2005 Mar; 61(1):208-16. PubMed ID: 15737095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selecting factors predictive of heterogeneity in multivariate event time data.
    Dunson DB; Chen Z
    Biometrics; 2004 Jun; 60(2):352-8. PubMed ID: 15180660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicting event times in clinical trials when treatment arm is masked.
    Donovan JM; Elliott MR; Heitjan DF
    J Biopharm Stat; 2006 May; 16(3):343-56. PubMed ID: 16724489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An extended general location model for causal inferences from data subject to noncompliance and missing values.
    Peng Y; Little RJ; Raghunathan TE
    Biometrics; 2004 Sep; 60(3):598-607. PubMed ID: 15339281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maximum likelihood estimation in survival studies under progressive interval censoring with random removals.
    Xiang L; Tse SK
    J Biopharm Stat; 2005; 15(6):981-91. PubMed ID: 16279356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.